EQS-DD: Pentixapharm Holding AG: Dr. Dirk Pleimes, Allocation of 400 spin-off shares in Pentixapharm Holding AG due to the ownership of 400 shares in Eckert & Ziegler SE.

08.10.24 13:40 Uhr

Werte in diesem Artikel




Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

08.10.2024 / 13:40 CET/CEST
The issuer is solely responsible for the content of this announcement.








1. Details of the person discharging managerial responsibilities / person closely associated

a) Name




Title: Dr.
First name: Dirk
Last name(s): Pleimes

2. Reason for the notification

a) Position / status




Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Pentixapharm Holding AG

b) LEI
3912005VBOVXNDXEQZ36 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code




Type: Share
ISIN: DE000A40AEG0

b) Nature of the transaction


Allocation of 400 spin-off shares in Pentixapharm Holding AG due to the ownership of 400 shares in Eckert & Ziegler SE.

c) Price(s) and volume(s)




Price(s) Volume(s)
5.10 EUR 2040.00 EUR

d) Aggregated information




Price Aggregated volume
not numberable not numberable

e) Date of the transaction
03/10/2024; UTC+2

f) Place of the transaction




Name: Frankfurt Stock Exchange
MIC: XFRA



08.10.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
















Language: English
Company: Pentixapharm Holding AG
Robert-Rössle-Straße 10
13125 Berlin
Germany
Internet: https://www.pentixapharm.com/



 
End of News EQS News Service





94669  08.10.2024 CET/CEST





Ausgewählte Hebelprodukte auf Pentixapharm

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Pentixapharm

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Pentixapharm Holding AG Unitary